Parallel Bio | Company Profile - Revenue, Headcount, Tech Stack, Contacts

Parallel Bio is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. The company has developed a unique platform that replicates the human immune system in a dish, utilizing human immune organoids—3D tissue models that mimic the structure and function of human lymph nodes. This innovative approach, combined with artificial intelligence and robotics, aims to enhance drug discovery and development by providing more accurate models of human disease compared to traditional animal testing.

The mission is to transform immunotherapy discovery by replacing animal models with human-derived organoids. This method addresses significant challenges in drug development, as many new drugs fail in clinical trials due to inaccurate predictions from animal testing. The technology seeks to reduce drug development timelines and costs while accelerating the delivery of safer and more effective therapies. Offerings include an Immune Organoid Platform, Trial-in-a-Dish services, patient-matched disease modeling, and target discovery, all designed to improve medication development and outcomes for patients.